Innovative Medtech Files 10-Q, Reports $500M Authorized Shares
Ticker: IMTH · Form: 10-Q · Filed: Feb 19, 2025 · CIK: 1331612
| Field | Detail |
|---|---|
| Company | Innovative Medtech, Inc. (IMTH) |
| Form Type | 10-Q |
| Filed Date | Feb 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financing, subsequent-event
TL;DR
IMTH 10-Q filed: $500M shares, $130M debt authorized. New promissory notes signed Feb 2025.
AI Summary
Innovative Medtech, Inc. filed its 10-Q for the period ending December 31, 2024. The company reported $500 million in authorized shares and $130 million in authorized debt. A significant subsequent event involved a Promissory Note Agreement entered into on February 1, 2025, with a related agreement on February 5, 2025.
Why It Matters
This filing provides insight into Innovative Medtech's capital structure and recent financing activities, which could impact future growth and operational flexibility.
Risk Assessment
Risk Level: medium — The company has significant authorized debt and equity, and recent promissory note agreements suggest potential financing needs or obligations.
Key Numbers
- $500.0M — Authorized Shares (Indicates potential for significant equity financing.)
- $130.0M — Authorized Debt (Shows capacity for debt financing.)
- 2025-02-01 — Promissory Note Agreement (A key subsequent event indicating recent financing activity.)
Key Players & Entities
- INNOVATIVE MEDTECH, INC. (company) — Filer
- 20241231 (date) — Period of Report
- 500000000 (dollar_amount) — Authorized Shares
- 130000000 (dollar_amount) — Authorized Debt
- 2025-02-01 (date) — Promissory Note Agreement Date
- 2025-02-05 (date) — Promissory Note Agreement Date
FAQ
What is the total amount of authorized debt for Innovative Medtech, Inc. as of the filing date?
The company has $130,000,000 in authorized debt.
When was the Promissory Note Agreement entered into?
A Promissory Note Agreement was entered into on February 1, 2025, with a related agreement on February 5, 2025.
What is the reporting period for this 10-Q filing?
The conformed period of report is December 31, 2024.
What was the company's former name before 'Innovative Medtech, Inc.'?
The company was formerly known as Fresh Harvest Products, Inc., Serino 1, Corp., and Serion 1, Corp.
What is the fiscal year end for Innovative Medtech, Inc.?
The fiscal year end for the company is June 30.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on February 19, 2025 regarding INNOVATIVE MEDTECH, INC. (IMTH).